NPPB and chronic kidney disease: A meta-analysis of 3,460 individuals with HF and CKD found that ARNI treatment significantly increased eGFR and decreased systolic BP, diastolic BP, and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) compared to ACEi or ARB (69).